|Packaging Size||1 Vial|
|Dose||Take Ocrelizumab vial only as per the dose and duration suggested by your doct|
|Preferred Mode Of Treatment||Hospitals|
Ocrelizumab 300mg injection is acd20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis.
what are side effects ofocrelizumab? Common side effects ofocrelizumab include:
upper respiratory tract infections,infusion reactions (itching, rash, hives, redness, bronchospasm, swollen and sore throat, mouth pain, shortness of breath, flushing, hypotension, fever, fatigue, headache, dizziness, nausea, and fast heart rate),skin infections,lower respiratory tract infections,depression,back pain, andpain in the extremities. Dosage forocrelizumabhepatitis b virus screening is required before the first dose ofocrelizumab. Pre-medicate with methylprednisolone (or an equivalent corticosteroid) and an antihistamine prior to each infusion. The starting dose ofocrelizumab is 300 mg intravenous infusion, followed two weeks later by a second 300 mg intravenous infusion. Subsequent doses ofocrelizumab are 600 mg intravenous infusion every 6 months.
what drugs, substances, or supplements interact withocrelizumab? Ocrevus may interact with other immune-modulating or immunosuppressive therapies, including immunosuppressant doses of corticosteroids. Tell your doctor all medications and supplements you use.
ocrevus during pregnancy and breastfeedingocrevus is not recommended for use during pregnancy; it may harm a fetus. It is unknown ifocrelizumab passes into breast milk. Consult your doctor before breastfeeding.
additional informationourocrelizumab (ocrelizumab) injection side effects drug center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
this is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to fda at 1-800-fda-1088.
some side effects may occur during the injection or up to 24 hours later. Tell your caregiver right away if you feel dizzy, tired, nauseated, light-headed, feverish, sweaty, itchy, or have a red skin rash, headache, fast heartbeats, chest tightness, trouble breathing, or swelling and irritation in your throat.
fast heart beats, tiredness;headache, nausea, dizziness;itchy skin, rash, hives;fever, chills, cough;throat pain or irritation;wheezing, breathing problem, feeling short of breath;flushing (sudden warmth, redness, or tingly feeling);skin sores, blisters, pus, or oozing;cold sores or fever blisters on or around your lips;nerve pain (tingling, burning pain, "pins and needles" feeling);mood or behavior changes, confusion, memory problems;weakness on one side of your body; orproblems with speech, vision, or muscle movement. Your ocrelizumab treatments may be delayed or permanently discontinued if you have certain side effects.
common side effects may include:
skin infections;reactions to an injection; orcold symptoms such as stuffy nose, sneezing, sore throat.
- Production Capacity: NA
- Delivery Time: Immediate
- Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them.
Parallel trade if any is conducted under WTO’s TRIPS agreement to which India is a Signatory.
On this page we have made an “Honest Reference” of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.